Supernus Pharmaceuticals
✓ Verified ManufacturerAbout
Supernus Pharmaceuticals stands as a distinguished biopharmaceutical company with over three decades of expertise in developing and commercializing innovative treatments for central nervous system diseases. Based in Rockville, Maryland, this award-winning organization has established itself as a leader in CNS therapeutic development, combining advanced research capabilities with proven commercial success. The company specializes in the comprehensive development lifecycle of pharmaceutical products, from initial research and clinical trials through regulatory approval and market commercialization. Supernus maintains a robust pipeline of CNS-focused treatments, including their recently approved medication Qelbree, demonstrating their commitment to addressing critical neurological and psychiatric conditions that affect millions of patients worldwide. With state-of-the-art research and development facilities, Supernus leverages cutting-edge pharmaceutical technologies and methodologies to advance novel therapeutic solutions. Their integrated approach encompasses drug discovery, formulation development, clinical research, regulatory affairs, and commercial manufacturing capabilities. The company operates under stringent quality assurance protocols and regulatory compliance standards essential in pharmaceutical manufacturing. Supernus serves healthcare providers, patients, and caregivers through comprehensive support programs and educational resources. Their dedicated team combines scientific excellence with market insight to deliver meaningful therapeutic advances in neurology and psychiatry. The organization continues expanding its CNS portfolio while maintaining operational excellence in pharmaceutical development and manufacturing processes.